Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Guido Sabatella"'
Autor:
Achim Berthele, Michael Levy, Dean M. Wingerchuk, Sean J. Pittock, Shulian Shang, Adrian Kielhorn, Minying Royston, Guido Sabatella, Jacqueline Palace
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundCumulative damage from multiple relapses in neuromyelitis optica spectrum disorder (NMOSD) is associated with poor health-related quality of life (HRQoL) and long-term disability in patients positive for anti-aquaporin 4 antibodies (AQP4+).
Externí odkaz:
https://doaj.org/article/7dcd6b20c6ed44b39cb3c1f119ab5c3b
Autor:
Achim Berthele, Michael Levy, Dean M. Wingerchuk, Sean J. Pittock, Shulian Shang, Adrian Kielhorn, Minying Royston, Guido Sabatella, Jacqueline Palace
BackgroundCumulative damage from multiple relapses in neuromyelitis optica spectrum disorder (NMOSD) is associated with poor health-related quality of life (HRQoL) and long-term disability in patients positive for anti-aquaporin 4 antibodies (AQP4+).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030a5a315bc47770716c93e1f8b34a7c
https://mediatum.ub.tum.de/1707434
https://mediatum.ub.tum.de/1707434
Autor:
Ilene C. Weitz, Sunil Mehta, Sean J. Pittock, James F. Howard, Jeremy Franklin, Guido Sabatella
Publikováno v:
CNS spectrums. 26(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94d5cdedd804be78567562ce652e7c6a
https://pubmed.ncbi.nlm.nih.gov/31747983
https://pubmed.ncbi.nlm.nih.gov/31747983
Autor:
Steven J. Greenberg, Ping Wang, Glenn Phillips, Heinz Wiendl, Gavin Giovannoni, Stanley Cohan, Krzysztof Selmaj, Wei Ma, Ludwig Kappos, Guido Sabatella, John W. Rose, Gabriel Paiva da Silva Lima, Eva Havrdova
Publikováno v:
Multiple Sclerosis (Houndmills, Basingstoke, England)
Background: Demonstration of clinical benefits on disability progression measures is an important attribute of effective multiple sclerosis (MS) treatments. Objective: Examine efficacy of daclizumab beta versus intramuscular (IM) interferon beta-1a o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2879fc97b3b2b642838e0e1900ff5144
https://doi.org/10.1177/1352458517735190
https://doi.org/10.1177/1352458517735190
Autor:
Stanley Cohan, Sharon G. Lynch, Jacob Elkins, Wanda Castro-Borrero, Katherine Riester, Guido Sabatella, Ping Wang, Ralph H.B. Benedict
Publikováno v:
Multiple Sclerosis (Houndmills, Basingstoke, England)
Background: Cognitive impairment is common in multiple sclerosis (MS), with cognitive processing speed being the most frequently affected domain. Objective: Examine the effects of daclizumab beta versus intramuscular (IM) interferon (IFN) beta-1a on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251acc4617bbf8f8ac23cf2bf71e5444
https://doi.org/10.1177/1352458517707345
https://doi.org/10.1177/1352458517707345
Autor:
Scott D. Newsome, Xiaojun You, Leslie Leahy, Vladimir Evilevitch, Christopher Robertson, June Halper, Guido Sabatella, Diego Centonze, De Ren Huang
Publikováno v:
International Journal of MS Care. 18:211-218
Background: Flu-like symptoms (FLSs) and injection-site reactions (ISRs) have been reported with interferon beta treatments for multiple sclerosis (MS). We sought to obtain consensus on the characteristics/management of FLSs/ISRs in patients with rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3865cd648b7e74f1c02e81638e24c30e
https://doi.org/10.7224/1537-2073.2015-042
https://doi.org/10.7224/1537-2073.2015-042
Autor:
Guido Sabatella, Shien Guo, Glenn Phillips, Irina Proskorovsky, Xiaojun You, Arman Altincatal, Elizabeth Kinter, Scott D. Newsome
Publikováno v:
Multiple Sclerosis and Related Disorders. 4:350-357
The Phase III ADVANCE study has shown clinical benefits for peginterferon beta-1a 125 µg dosed every 2 weeks versus placebo at 1 year in patients with relapsing-remitting multiple sclerosis (MS). This study assessed the impact of peginterferon beta-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f07d0f26c57fd179466dee9fc0f46f42
https://doi.org/10.1016/j.msard.2015.06.004
https://doi.org/10.1016/j.msard.2015.06.004
Autor:
Ying Liu, Timothy Vollmer, Glenn Phillips, Eva Havrdova, Katherine Riester, Guido Sabatella, Ping Wang, Andrew Lee
Publikováno v:
Multiple sclerosis and related disorders. 11
Background Patient-reported outcomes (PROs) provide information on treatment effects from the patient's perspective that complement outcomes on clinical measures. In DECIDE, daclizumab demonstrated superior efficacy in reducing relapses, 24-week conf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cf61c1b1415bf126637c373324a9dd
https://pubmed.ncbi.nlm.nih.gov/28104250
https://pubmed.ncbi.nlm.nih.gov/28104250
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 89:A29.1-A29
IntroductionThe 5 year, observational, phase 4 POP study explores the long-term safety and effectiveness of peginterferon beta-1a 125 mcg every 2 weeks in RRMS patients treated in real-world settings. This analysis presents interim data from POP on b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aace48e33197abf63fbc0069292c5a16
https://doi.org/10.1136/jnnp-2018-anzan.69
https://doi.org/10.1136/jnnp-2018-anzan.69
Autor:
Angela Greco, Cristiano Rumio, Paola Bressan, Guido Sabatella, Emanuela Roccato, L. Vizzotto, Marco A. Pierotti
Publikováno v:
Cancer Research. 65:2572-2576
Chromosomal rearrangements are frequently associated with cancer; the mechanisms underlying their cell-type specificity are poorly understood. Papillary thyroid carcinomas are marked by a high frequency of chromosome rearrangements involving the RET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73cd57a0e0769f6efae75703af6817a8
https://doi.org/10.1158/0008-5472.can-04-4294
https://doi.org/10.1158/0008-5472.can-04-4294